News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Lewis Michael E
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/10/2017 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc. |
06/17/2016 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $5.81, valued at
$116.2k
|
|
01/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/06/2015 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 7,262 shares
@ $11.66, valued at
$84.7k
|
|
06/02/2015 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 7,262 shares
@ $9.5, valued at
$69k
|
|
05/05/2015 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 7,262 shares
@ $10.64, valued at
$77.3k
|
|
04/02/2015 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 7,262 shares
@ $9.9, valued at
$71.9k
Sold 7,262 shares
@ $9.9, valued at
$71.9k
|
|
03/03/2015 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 7,262 shares
@ $10.11, valued at
$73.4k
|
|
02/03/2015 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 7,262 shares
@ $10.6, valued at
$77k
|
|
02/05/2014 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Converted 40,000 shares
@ $0 Converted 3,572 shares
@ $0 Converted 100,000 preferred shares
@ $0 Converted 8,931 preferred shares
@ $0 |
|
01/31/2014 |
4
| Lewis Michael E (Chief Scientific Advisor) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $11, valued at
$440k
|
|
05/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/06/2013 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns:
| Granted 11,250 options to buy
@ $0.5, valued at
$5.6k
Granted 11,250 options to buy
@ $0.4, valued at
$4.5k
Granted 11,250 options to buy
@ $0.23, valued at
$2.6k
Granted 11,250 options to buy
@ $0.35, valued at
$3.9k
|
|
03/28/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/24/2011 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns:
| Granted 11,250 options to buy
@ $0.4, valued at
$4.5k
|
|
01/25/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/20/2011 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns:
| Granted 11,250 options to buy
@ $0.75, valued at
$8.4k
Granted 11,250 options to buy
@ $0.75, valued at
$8.4k
|
|
12/16/2010 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns:
| Granted 11,250 options to buy
@ $0.6, valued at
$6.8k
|
|
11/19/2010 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns:
| Granted 11,250 options to buy
@ $0.57, valued at
$6.4k
|
|
10/01/2010 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns:
| Granted 11,250 options to buy
@ $0.39, valued at
$4.4k
Granted 11,250 options to buy
@ $0.4, valued at
$4.5k
|
|
09/07/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/30/2009 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC. |
06/05/2009 |
4
| Lewis Michael E (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC. |
02/03/2009 |
4
| Lewis Michael E (Director) has filed a Form 4 on POLYMEDIX INC |
|
|